Effects of Intravenous Metabolic Recovery Agent in Elderly Septic Patients on Prognosis and Microcirculation.
Trial Parameters
Brief Summary
This study intends to observe the effect of intravenous hydrocortisone combined with vitamin C and vitamin B1 infusion on the prognosis and sublingual microcirculation in patients with sepsis or septic shock through a prospective randomized controlled study method.
Eligibility Criteria
Inclusion Criteria: * Age ≥60 and ≤85 years old; * Diagnosis of sepsis or septic shock; * Clinical judgment for hydrocortisone treatment; * Signing Informed Consent. Exclusion Criteria: * patients in palliative care; * uncontrolled malignancy with multiple metastases; * ineffective surgical intervention for the infectious agent; * estimated death within 24 hours; * glucocorticoids used in the last 7 days; * allergy to hydrocortisone, vitamin c or vitamin B1; * inability to measure sublingual microcirculation.